Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haesook T Kim

Showing results (41-50 of 191) with videos related to

Pageof 20
Sort By:
Blood Advances|October 19, 2021
Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplantMary Nauffal, Haesook T Kim, Paul G Richardson, et al.
Leukemia & Lymphoma|March 30, 2026
Allogeneic transplant outcomes in T-cell prolymphocytic leukemia: a single-center retrospective studyMwanasha Merrill, Haesook T Kim, Amar H Kelkar, et al.
Haematologica|March 26, 2017
Venous thromboembolism is associated with graft-<i>versus</i>-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantationNatasha Kekre, Haesook T Kim, Vincent T Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 13, 2011
The impact of geographic proximity to transplant center on outcomes after allogeneic hematopoietic stem cell transplantationKarim E Abou-Nassar, Haesook T Kim, Jeff Blossom, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2010
Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndromeJohn Koreth, Melinda Biernacki, Julie Aldridge, et al.
Blood|June 24, 2005
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host diseaseEmmanuel Zorn, Haesook T Kim, Stephanie J Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantationPhilippe Armand, Haesook T Kim, Daniel J DeAngelo, et al.
Blood|August 29, 2009
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donorsJohn Koreth, Kristen E Stevenson, Haesook T Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2010
Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopesYishai Ofran, Haesook T Kim, Vladimir Brusic, et al.
Blood|May 6, 2003
Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantationJoseph H Antin, Haesook T Kim, Corey Cutler, et al.
Pageof 20

Showing results (41-50 of 191) with videos related to

Sort By:
Pageof 20
Blood Advances|October 19, 2021
Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplantMary Nauffal, Haesook T Kim, Paul G Richardson, et al.
Leukemia & Lymphoma|March 30, 2026
Allogeneic transplant outcomes in T-cell prolymphocytic leukemia: a single-center retrospective studyMwanasha Merrill, Haesook T Kim, Amar H Kelkar, et al.
Haematologica|March 26, 2017
Venous thromboembolism is associated with graft-<i>versus</i>-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantationNatasha Kekre, Haesook T Kim, Vincent T Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 13, 2011
The impact of geographic proximity to transplant center on outcomes after allogeneic hematopoietic stem cell transplantationKarim E Abou-Nassar, Haesook T Kim, Jeff Blossom, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2010
Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndromeJohn Koreth, Melinda Biernacki, Julie Aldridge, et al.
Blood|June 24, 2005
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host diseaseEmmanuel Zorn, Haesook T Kim, Stephanie J Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantationPhilippe Armand, Haesook T Kim, Daniel J DeAngelo, et al.
Blood|August 29, 2009
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donorsJohn Koreth, Kristen E Stevenson, Haesook T Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2010
Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopesYishai Ofran, Haesook T Kim, Vladimir Brusic, et al.
Blood|May 6, 2003
Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantationJoseph H Antin, Haesook T Kim, Corey Cutler, et al.
Pageof 20